1. Home
  2. SLRX vs MGIC Comparison

SLRX vs MGIC Comparison

Compare SLRX & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • MGIC
  • Stock Information
  • Founded
  • SLRX N/A
  • MGIC 1983
  • Country
  • SLRX United States
  • MGIC Israel
  • Employees
  • SLRX N/A
  • MGIC N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • SLRX Health Care
  • MGIC Technology
  • Exchange
  • SLRX Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • SLRX 1.8M
  • MGIC 788.0M
  • IPO Year
  • SLRX N/A
  • MGIC 1991
  • Fundamental
  • Price
  • SLRX $0.64
  • MGIC $20.76
  • Analyst Decision
  • SLRX
  • MGIC Buy
  • Analyst Count
  • SLRX 0
  • MGIC 2
  • Target Price
  • SLRX N/A
  • MGIC $16.00
  • AVG Volume (30 Days)
  • SLRX 3.6M
  • MGIC 95.5K
  • Earning Date
  • SLRX 08-08-2025
  • MGIC 08-13-2025
  • Dividend Yield
  • SLRX N/A
  • MGIC 2.73%
  • EPS Growth
  • SLRX N/A
  • MGIC 1.33
  • EPS
  • SLRX N/A
  • MGIC 0.76
  • Revenue
  • SLRX N/A
  • MGIC $569,136,000.00
  • Revenue This Year
  • SLRX N/A
  • MGIC $7.53
  • Revenue Next Year
  • SLRX N/A
  • MGIC $8.96
  • P/E Ratio
  • SLRX N/A
  • MGIC $28.25
  • Revenue Growth
  • SLRX N/A
  • MGIC 6.37
  • 52 Week Low
  • SLRX $0.45
  • MGIC $9.64
  • 52 Week High
  • SLRX $7.20
  • MGIC $22.00
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 41.73
  • MGIC 68.91
  • Support Level
  • SLRX $0.66
  • MGIC $20.17
  • Resistance Level
  • SLRX $0.90
  • MGIC $22.00
  • Average True Range (ATR)
  • SLRX 0.12
  • MGIC 0.54
  • MACD
  • SLRX -0.03
  • MGIC 0.15
  • Stochastic Oscillator
  • SLRX 16.46
  • MGIC 70.79

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

Share on Social Networks: